Diagnostics Inc reports results for the quarter ended in September - Earnings Summary

Co-Diagnostics

10/11/2022 22:02

* Co-Diagnostics Inc  CODX.OQ  reported a quarterly adjusted
loss
of 4 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 4 cents per share.
    * Revenue fell 83.1% to $5.09 million from a year ago;
analysts
expected $7.98 million. 
    * Co-Diagnostics Inc's reported EPS for the quarter was a
loss
of 4 cents​.
    * The mean earnings estimate of analysts had fallen by
about 145.5% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Co-Diagnostics Inc shares had risen by 4.5% this
quarter and
lost 62.4% so far this year.
    * The company reported a quarterly loss of $1.36 million.
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.04          -0.04          Met
 Jun. 30 2022      0.10           -0.08          Missed
 Mar. 31 2022      0.17           0.34           Beat
 Dec. 31 2021      0.12           0.25           Beat